<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Comparison of clinical manifestations and laboratory tests with different EVs infected patients</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>Total</th>
    <th>CVA-6</th>
    <th>CVA-10</th>
    <th>CVA-16</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="5">Clinical symptoms and signs</td>
   </tr>
   <tr>
    <td>Total patients</td>
    <td>N = 1220</td>
    <td>N = 364</td>
    <td>N = 305</td>
    <td>N = 397</td>
   </tr>
   <tr>
    <td> Cough</td>
    <td>304(24.9%)</td>
    <td>101(27.7%)</td>
    <td>65(21.3%)</td>
    <td>96(24.2%)</td>
   </tr>
   <tr>
    <td> Diarrhea</td>
    <td>60(4.9%)</td>
    <td>14(3.8%)</td>
    <td>14(4.6%)</td>
    <td>22(5.5%)</td>
   </tr>
   <tr>
    <td> Vomiting</td>
    <td>228(18.7%)</td>
    <td>60(16.5%)</td>
    <td>67(22.0%)</td>
    <td>79(19.9%)</td>
   </tr>
   <tr>
    <td> Fever spike (°C)</td>
    <td>39.3(39.0–39.8)</td>
    <td>39.4(39.0–39.8)</td>
    <td>39.5(39.0–39.9)</td>
    <td>39.0(38.9–39.9)</td>
   </tr>
   <tr>
    <td> Fever (&gt; 38 °C)</td>
    <td>1093(89.6%)</td>
    <td>327(89.8%)</td>
    <td>280(91.8%)</td>
    <td>360(90.7%)</td>
   </tr>
   <tr>
    <td> Neurologic complications</td>
    <td>61(5.0%)</td>
    <td>20(5.5%)</td>
    <td>16(5.2%)</td>
    <td>6(1.5%)
     <sup>*</sup>
    </td>
   </tr>
   <tr>
    <td> Skin lesion</td>
    <td>1220(100%)</td>
    <td>364(100%)</td>
    <td>305(100%)</td>
    <td>397(100%)</td>
   </tr>
   <tr>
    <td> Mouth and/or pharyngeal</td>
    <td>1056(86.6%)</td>
    <td>300(82.4%)</td>
    <td>270(88.5%)</td>
    <td>340(85.7%)</td>
   </tr>
   <tr>
    <td> Hands and /or feet</td>
    <td>1117(91.6%)</td>
    <td>339(93.1%)</td>
    <td>264(86.6%)</td>
    <td>354(89.2%)</td>
   </tr>
   <tr>
    <td> Trunk</td>
    <td>210(17.2%)</td>
    <td>76(20.9%)</td>
    <td>51(16.7%)</td>
    <td>72(18.1%)</td>
   </tr>
   <tr>
    <td> Extremities</td>
    <td>1115(91.4%)</td>
    <td>342(94.0%)</td>
    <td>267(87.5%)</td>
    <td>362(91.2%)</td>
   </tr>
   <tr>
    <td colspan="5">Laboratory data</td>
   </tr>
   <tr>
    <td>Total patients</td>
    <td>
     <italic>N</italic> = 1220
    </td>
    <td>
     <italic>N</italic> = 364
    </td>
    <td>
     <italic>N</italic> = 305
    </td>
    <td>
     <italic>N</italic> = 397
    </td>
   </tr>
   <tr>
    <td> hsCRP(0-10 mg/L)</td>
    <td>6.93(2.50–17.08)</td>
    <td>9.67(3.68–22.84)</td>
    <td>14.26(3.92–27.3)</td>
    <td>4.23(2.50–8.90)
     <sup>*</sup>
    </td>
   </tr>
   <tr>
    <td> hsCRP (&gt; 2.5 mg/L)</td>
    <td>868(71.1%)</td>
    <td>293(80.5%)
     <sup>*</sup>
    </td>
    <td>236(77.4%)</td>
    <td>246(62.0%)</td>
   </tr>
   <tr>
    <td> WBC(5-12 × 10
     <sup>9</sup>/L)
    </td>
    <td>9.9(7.8–12.6)</td>
    <td>9.3(7.1–12.5)</td>
    <td>11.9(8.9–14.6)
     <sup>*</sup>
    </td>
    <td>9.48(7.8–11.3)</td>
   </tr>
   <tr>
    <td> WBC &gt; 12 × 10
     <sup>9</sup>/L
    </td>
    <td>362(29.7%)</td>
    <td>110(30.2%)</td>
    <td>146(47.9%)
     <sup>*</sup>
    </td>
    <td>74(18.6%)</td>
   </tr>
   <tr>
    <td> Neutrophils (3-10 × 10
     <sup>9</sup>/L)
    </td>
    <td>5.3(3.4–8.0)</td>
    <td>4.3(2.7–8.1)</td>
    <td>7.1(4.5–10.1)
     <sup>*</sup>
    </td>
    <td>4.9(3.7–6.5)</td>
   </tr>
   <tr>
    <td> Neutrophils(&gt; 10 × 10
     <sup>9</sup>/L)
    </td>
    <td>167(13.7%)</td>
    <td>53(14.6%)</td>
    <td>80(26.2%)
     <sup>*</sup>
    </td>
    <td>20(5.0%)</td>
   </tr>
   <tr>
    <td> Lymphocyte (1.1–3.2 × 10
     <sup>9</sup>/L)
    </td>
    <td>3.1(2.3–4.1)</td>
    <td>3.2(2.4–4.3)</td>
    <td>3.0(2.2–3.9)</td>
    <td>3.2(2.4–4.2)</td>
   </tr>
   <tr>
    <td> Lymphocyte(&gt; 3.2 × 10
     <sup>9</sup>/L)
    </td>
    <td>563(46.1%)</td>
    <td>197(49.2%)</td>
    <td>126(41.3%)</td>
    <td>196(49.4%)</td>
   </tr>
   <tr>
    <td>  PLT (150-400 × 10
     <sup>9</sup>/L)
    </td>
    <td>274(231–329)</td>
    <td>274(232–334)</td>
    <td>273(229–339)</td>
    <td>278(227–324)</td>
   </tr>
   <tr>
    <td> PLT(&gt; 400 × 10
     <sup>9</sup>/L)
    </td>
    <td>109(8.9%)</td>
    <td>30(8.2%)</td>
    <td>26(8.5%)</td>
    <td>36(9.1%)</td>
   </tr>
   <tr>
    <td>Total patients</td>
    <td>
     <italic>N</italic> = 758
    </td>
    <td>
     <italic>N</italic> = 236
    </td>
    <td>
     <italic>N</italic> = 204
    </td>
    <td>
     <italic>N</italic> = 246
    </td>
   </tr>
   <tr>
    <td> AST (30-40 U/L)</td>
    <td>36(31–41)</td>
    <td>35(30–41)</td>
    <td>36(32–40)</td>
    <td>36(31–41)</td>
   </tr>
   <tr>
    <td> AST(&gt; 40 U/L)</td>
    <td>183(24.1%)</td>
    <td>60(25.4%)</td>
    <td>45(22.1%)</td>
    <td>66(26.8%)</td>
   </tr>
   <tr>
    <td> CK (30-135 U/L)</td>
    <td>94(72–118)</td>
    <td>90(69–111)</td>
    <td>96(75–120)</td>
    <td>97(72–126)</td>
   </tr>
   <tr>
    <td> CK(&gt; 135 U/L)</td>
    <td>126(16.6%)</td>
    <td>50(21.2%)</td>
    <td>36(17.6%)</td>
    <td>34(13.8%)</td>
   </tr>
   <tr>
    <td> CK-MB(0-25 U/L)</td>
    <td>20(16–25)</td>
    <td>21(16–25)</td>
    <td>19(15–24)</td>
    <td>22(16–25)</td>
   </tr>
   <tr>
    <td> CK-MB(&gt; 25 U/L)</td>
    <td>169(22.3%)</td>
    <td>52(22.0%)</td>
    <td>43(21.1%)</td>
    <td>60(24.4%)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Continuous data are presented as median (interquartile range) and categorical data are presented as n (%)</p>
  <p>* Significant different compare with other groups, 
   <italic>P</italic> &lt; 0.05
  </p>
 </table-wrap-foot>
</table-wrap>
